Free SOCRA SOCRA-CCRP Exam Questions

Become SOCRA Certified with updated SOCRA-CCRP exam questions and correct answers

Page: 1 / 27

Total 131 Questions | Updated On: Jun 15, 2026

Add To Cart

Question 1

A clinical investigator terminated a Phase IV drug study. In accordance with the ICH GCP Guidelines, which of the following documents should the clinical investigator maintain?

A : The master randomization list

B : The completed subject identification code list

C : The final trial closeout monitoring report

D : The audit certificate

Answer: B

Question 2

A sponsor is permitted to charge for an investigational drug but must provide what documentation?

A : CMS approval letter

B : Orphan product evidence

C : IRB attestation of institutional cost burden

D : Evidence of potential clinical benefit and significant advantage

Answer: D

Question 3

A revised protocol added genomic testing to banked tissue samples. Before shipping samples, what must the site do?

A : Execute material transfer agreement

B : Ship under dangerous goods requirements

C : Obtain IRB/IEC approval for revised protocol and ICF

D : Notify enrolled subjects

Answer: C

Question 4

In order to adequately monitor a clinical trial, the monitor must be familiar with each of the following, EXCEPT the:

A : Written information to be provided to the subjects

B : Requirements for storage of the investigational product

C : Sponsor's SOPs

D : IRB/IEC requirements for reporting to the regulatory authority

Answer: D

Question 5

Which of the following is one of the responsibilities of an investigator who is NOT a sponsor?

A : Reporting serious adverse events to the applicable regulatory agency

B : Ensuring proper monitoring of an investigation at all investigational sites

C : Ensuring that all participating investigators are promptly informed of significant new adverse events

D : Maintaining control of the investigational product

Answer: D

Page: 1 / 27

Total 131 Questions | Updated On: Jun 15, 2026

Add To Cart